Menu

Alan Rabson, Former Deputy Director of the NCI, Dies

Rabson’s career at the National Cancer Institute spanned six decades.

Jul 6, 2018
Sukanya Charuchandra
Alan Rabson
NCI

Alan Rabson, whose research career at the National Cancer Institute lasted six decades and culminated with his role as deputy director for 20 years, died on July 4. He was 92.

“We have lost a giant,” says Norman Sharpless, the director of the NCI, in a statement.

Born and raised in New York City, Rabson obtained a medical degree from the State University of New York. He started his career at the NCI in 1955 after a failed attempt at acquiring an internship at the organization in 1947 and a lack of opportunities in the early 1950s.. According to the NCI’s oral history project, Rabson spent his first year at the NCI as a resident in the pathology department with only a desk and a microscope for his laboratory. In the following year, he was given a fully functioning lab and a technician.

Rabson studied tumor-causing viruses, working extensively as a pathologist, virologist, and clinical researcher. Rabson was known for his dedication to clinical care, helping many cancer patients find the right treatment and clinical trial. Since 2012, the Alan S. Rabson Award for Clinical Care has been given to individuals likeminded for their efforts to help NIH patients.

In 1975, he was named the director of the precursor to the NCI’s cancer biology division, and from 1995 to his retirement in 2015, Rabson was the deputy director of the NCI.

“He had an inimitable leadership style,” Doug Lowy, the current deputy director of NCI, says in the statement. “When you talked with him, he spent most of the time trying to understand what you needed, so he could help you, rather than spending it figuring out how you could help him. He truly believed that if you were successful, he was successful.”

Along with his wife Ruth Kirschstein, a scientist who passed away in 2009, Rabson was a prominent leader within the NIH community. Additionally, he was a professor at George Washington University and Georgetown University. After hearing of Rabson’s death, Francis Collins, the NIH director, tweeted about his colleague, “Al always went the extra mile.”

April 2019

Will Car T Cells Smash Tumors?

New trials take the therapy beyond the blood

Marketplace

Sponsored Product Updates

Application of TruBIOME™ to Increase Mouse Model Reproducibility
Application of TruBIOME™ to Increase Mouse Model Reproducibility
With this application note from Taconic, learn about the effects of the microbiome on reproducibility and predictability and how TruBIOME™ helps researchers generate custom microbiota mouse models!
Getting More Consistent Results by Knowing the Quality of Your Protein
Getting More Consistent Results by Knowing the Quality of Your Protein
Download this guide from NanoTemper to learn how to identify and evaluate the quality of your protein samples!
Myth Busting: The Best Way to Use Pure Water in the Lab
Myth Busting: The Best Way to Use Pure Water in the Lab
Download this white paper from ELGA LabWater to learn about the role of pure water in the laboratory and the advantages of in-house water purification!
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu Corporation announces the release of the Nexera Ultra High-Performance Liquid Chromatograph series, incorporating artificial intelligence as Analytical Intelligence, allowing systems to detect and resolve issues automatically. The Nexera series makes lab management simple by integrating IoT and device networking, enabling users to easily review instrument status, optimize resource allocation, and achieve higher throughput.